BioHarvest Sciences (BHST) Income Statement (2023 - 2025)
Annual Income Statement report data from Dec 31, 2023 to Dec 31, 2025 for BioHarvest Sciences (BHST).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| 2025 | 2024 | 2023 | |
|---|---|---|---|
Revenue and COGS | |||
Total Revenue | 35M (+37.00%) | 25M (+98.82%) | 13M |
Cost Of Revenue | 14M (+24.71%) | 11M (+59.80%) | 7.04M |
Costof Goods And Services Sold | 14M (+24.71%) | 11M (+59.80%) | 7.04M |
Gross Profit | 20M (+46.92%) | 14M (+147.60%) | 5.63M |
Operating Expenses | |||
Research And Development | 5.31M (+10.63%) | 4.80M (+42.43%) | 3.37M |
Selling General And Administrative | 4.93M (+12.05%) | 4.40M (-1.79%) | 4.48M |
Operating Expenses | 26M (+24.46%) | 21M (+34.17%) | 16M |
Depreciation And Amortization | 1.62M (+29.60%) | 1.25M (+48.81%) | 840K |
Operating Income | |||
Operating Income | -5.57M (-20.31%) | -6.99M (-29.89%) | -9.97M |
Ebit | -5.57M (-20.31%) | -6.99M (-29.89%) | -9.97M |
EBITDA | -3.95M (-31.18%) | -5.74M (-37.13%) | -9.13M |
Net Income | |||
Income Before Tax | -11.06M (-14.26%) | -12.90M (+2.71%) | -12.56M |
Income Tax Expense | -80.00K (+700.00%) | -10.00K | - |
Net Income From Continuing Operations | -11.13M (-13.79%) | -12.91M (+2.79%) | -12.56M |
Net Income | -11.13M (-13.79%) | -12.91M (+2.79%) | -12.56M |